GLI1 activation is one of the mechanisms by which estrogen exposure promotes the proliferation and epithelial-mesenchymal transition of breast cancer stem cells[21], and GSK3β inactivation can inhibit the activation of GLI1[22]. Here, GLI1 is linked to breast carcinoma.